Literature DB >> 22429502

Hepatocellular adenoma subtypes: the impact of overweight and obesity.

Paulette Bioulac-Sage1, Said Taouji, Laurent Possenti, Charles Balabaud.   

Abstract

BACKGROUND: Hepatocellular adenomas (HCA) are rare benign tumours occurring mainly in women using oral contraceptives. With the appearance of a generation of new oral contraceptives, the number of HCA cases was anticipated to decrease, but in fact this was not observed in our practice. The influence of obesity was therefore suspected as a new co-factor. AIMS: The aim of this study was to analyze the impact of overweight/obesity in our cohort of HCA patients classified according to their subtypes.
RESULTS: The number of HCA noticeably increased faster in the 2001-2011 period compared to the 1990-2000 period. This phenomenon concurred with an increasing number of patients overweight or obese. Females still represented the great majority of overweight/obese patients presenting HCA, however, overweight/obese male patients constituted a new entity in the inflammatory HCA and β-catenin activated- inflammatory HCA subgroups.
CONCLUSION: We propose that overweight/obesity may soon represent a major risk of malignant transformation of HCA, possibly via the IL-6 pathway.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22429502     DOI: 10.1111/j.1478-3231.2012.02786.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  26 in total

Review 1.  Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management.

Authors:  Agustin Cristiano; Agustin Dietrich; Juan Carlos Spina; Victoria Ardiles; Eduardo de Santibañes
Journal:  Updates Surg       Date:  2013-06-27

Review 2.  Gd-EOB-DTPA-Enhanced Magnetic Resonance Findings of a Giant Inflammatory Hepatocellular Adenoma: a Case Report and Review of the Literature.

Authors:  Marco Di Pietropaolo; Chiara Briani; Emanuela Pilozzi; Francesco Carbonetti; Vincenzo David; Elsa Iannicelli
Journal:  J Gastrointest Cancer       Date:  2015-12

Review 3.  Hepatocellular adenoma management: advances but still a long way to go.

Authors:  Jean Frédéric Blanc; Nora Frulio; Laurence Chiche; Paulette Bioulac-Sage; Charles Balabaud
Journal:  Hepat Oncol       Date:  2015-05-15

Review 4.  Benign solid tumors of the liver: management in the modern era.

Authors:  Georgios Antonios Margonis; Aslam Ejaz; Gaya Spolverato; Neda Rastegar; Robert Anders; Ihab R Kamel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2015-01-06       Impact factor: 3.452

Review 5.  Malignant transformation of hepatocellular adenoma.

Authors:  Christine Sempoux; Charles Balabaud; Paulette Bioulac-Sage
Journal:  Hepat Oncol       Date:  2014-12-11

6.  Guidelines for the Treatment of Hepatocellular Adenoma in the Era of Molecular Biology: An Experience-Based Surgeons' Perspective.

Authors:  Paulo Herman; Gilton Marques Fonseca; Jaime Arthur Pirola Kruger; Vagner Birk Jeismann; Fabricio Ferreira Coelho
Journal:  J Gastrointest Surg       Date:  2020-07-14       Impact factor: 3.452

7.  Treatment of Hepatic Adenomatosis.

Authors:  Claire Meyer; Mauricio Lisker-Melman
Journal:  Curr Hepatol Rep       Date:  2015-05-02

Review 8.  Management of hepatic adenomatosis.

Authors:  Manish Thapar; Oleg Grapp; Constantine Fisher
Journal:  Curr Gastroenterol Rep       Date:  2015-03

9.  Short-term outcomes of laparoscopic vs. open liver resection for hepatocellular adenoma: a multicenter propensity score adjustment analysis by the AFC-HCA-2013 study group.

Authors:  Filippo Landi; Nicola De' Angelis; Olivier Scatton; Xavier Vidal; Ahmet Ayav; Fabrice Muscari; Safi Dokmak; Guido Torzilli; Nicolas Demartines; Olivier Soubrane; Daniel Cherqui; Jean Hardwigsen; Alexis Laurent
Journal:  Surg Endosc       Date:  2017-03-09       Impact factor: 4.584

10.  Association of cyclin D and estrogen receptor α36 with hepatocellular adenomas of female mice under chronic endoplasmic reticulum stress.

Authors:  Mo Yin Lau; Hui Han; Jay Hu; Cheng Ji
Journal:  J Gastroenterol Hepatol       Date:  2013-03       Impact factor: 4.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.